Skip to Main Content

Phase II Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma



Phase II

What is the purpose of this trial?

Phase II trial of nivolumab in 120 treatment naïve patients with ccRCC

  • Trial with
    Hoosier Cancer Research Network, Inc
  • Start Date
  • End Date

For more information about this study, contact:

Neta Shanwetter Levit

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 877.978.8343

  • Last Updated
  • Study HIC